BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26496463)

  • 1. Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma.
    Tonder M; Weller M; Eisele G; Roth P
    Chemotherapy; 2014; 60(5-6):375-8. PubMed ID: 26496463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
    Schäfer N; Tichy J; Thanendrarajan S; Kim Y; Stuplich M; Mack F; Rieger J; Simon M; Scheffler B; Boström J; Steinbach JP; Herrlinger U; Glas M
    Oncology; 2011; 80(5-6):330-2. PubMed ID: 21791942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
    Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
    Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
    Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.
    Gnekow AK; Walker DA; Kandels D; Picton S; Giorgio Perilongo ; Grill J; Stokland T; Sandstrom PE; Warmuth-Metz M; Pietsch T; Giangaspero F; Schmidt R; Faldum A; Kilmartin D; De Paoli A; De Salvo GL;
    Eur J Cancer; 2017 Aug; 81():206-225. PubMed ID: 28649001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
    Aoki T; Mizutani T; Nojima K; Takagi T; Okumura R; Yuba Y; Ueba T; Takahashi JA; Miyatake S; Nozaki K; Taki W; Matsutani M
    J Neurosurg; 2010 Jan; 112(1):50-6. PubMed ID: 19538050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
    Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
    Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma.
    Franceschi E; Cavallo G; Scopece L; Paioli A; Pession A; Magrini E; Conforti R; Palmerini E; Bartolini S; Rimondini S; Esposti RD; Crinò L
    Br J Cancer; 2004 Sep; 91(6):1038-44. PubMed ID: 15305187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
    Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
    J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin and etoposide for recurrent malignant glioma: one department's experience.
    Stein ME; Tzuk-Shina Z; Ravkin A; Drumea K; Goldsher D
    Am J Clin Oncol; 1998 Apr; 21(2):215-6. PubMed ID: 9537216
    [No Abstract]   [Full Text] [Related]  

  • 12. High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
    Dufour C; Grill J; Lellouch-Tubiana A; Puget S; Chastagner P; Frappaz D; Doz F; Pichon F; Plantaz D; Gentet JC; Raquin MA; Kalifa C
    Eur J Cancer; 2006 Nov; 42(17):2939-45. PubMed ID: 16962317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
    Scopece L; Franceschi E; Cavallo G; Paioli A; Paioli G; Conforti R; Palmerini E; Berzioli C; Spagnolli F; Esposti RD; Crinò L
    J Neurooncol; 2006 Sep; 79(3):299-305. PubMed ID: 16645720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined carboplatin and etoposide chemotherapy for patients with recurrent glioma.
    Chen J; Zhao Y; Hou X; Gao X; Shi Q; Li S; Huang H
    Ann Palliat Med; 2021 Dec; 10(12):12650-12656. PubMed ID: 35016422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution study.
    Hassler MR; Ackerl M; Flechl B; Sax C; Wöhrer A; Widhalm G; Dieckmann K; Hainfellner J; Preusser M; Marosi C
    Anticancer Drugs; 2014 Jul; 25(6):723-8. PubMed ID: 24441743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme.
    Francesconi AB; Dupre S; Matos M; Martin D; Hughes BG; Wyld DK; Lickliter JD
    J Clin Neurosci; 2010 Aug; 17(8):970-4. PubMed ID: 20541421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.
    Scheinemann K; Bartels U; Tsangaris E; Hawkins C; Huang A; Dirks P; Fried I; Bouffet E; Tabori U
    Pediatr Blood Cancer; 2011 Jul; 57(1):84-8. PubMed ID: 21557457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
    Villani V; Pace A; Vidiri A; Tanzilli A; Sperati F; Terrenato I; Mariantonia C; Casini B; Metro G; Maschio M; Tatiana K; Cognetti F; Fabi A
    J Neurooncol; 2019 Aug; 144(1):211-216. PubMed ID: 31273578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Carboplatin and Etoposide Combination Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma: A Retrospective Case Series.
    Imai H; Shirota H; Okita A; Komine K; Saijo K; Takahashi M; Takahashi S; Takahashi M; Shimodaira H; Ishioka C
    Chemotherapy; 2016; 61(3):111-6. PubMed ID: 26636658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.